Drugs & Diseases

Recent Drug Updates

  • semaglutide (Rybelsus) FDA approves first oral GLP-1 receptor agonist for type 2 diabetes
  • pembrolizumab (Keytruda) FDA approves PD-L1 inhibitor in combination with lenvatinib for advanced endometrial cancer
  • ceftaroline (Teflaro) Indication for acute bacterial skin and skin structure infections expanded to include all children, including newborns

Slideshow Collections